On Wednesday shares of BRF S.A. (NYSE:BRFS) closed at $22.11. Company’s sales growth for last 5 years was 12.80% and EPS growth for next 5 years is recorded as 39.59%. In compliance with article 157, paragraph 4, of Law No.6,404 of December 15, 1976, as amended, and in accordance with the Comissao de Valores Mobiliarios (“CVM”) Instruction No.358 of March 01, 2012, as amended, BRF S.A. (NYSE:BRFS) hereby announces that, the Board of Directors at a meeting held, approved the Company’s Share Buyback Program (“Share Buyback Program”) under the following conditions, pursuant to CVM Instruction No.10/80:

Synthetic Biologics Inc. (NYSEMKT:SYN) in last trading activity moved down -3.96% to close at $2.18. Company weekly performance is -5.63% while its quarterly performance stands at 26.74%. Synthetic Biologics Inc. (NYSEMKT:SYN) is -31.34% away from its 52 week high. Synthetic Biologics, Inc. (NYSEMKT:SYN), intends to release its financial results for the three months ended March 31, 2015 on Monday, May 11, 2015, and to host a conference call the same day at 4:30 p.m. EDT.

Siliconware Precision Industries Co. Ltd. (NASDAQ:SPIL) has institutional ownership stands at 7.50%. In last trading activity company’s stock closed at $8.03. Siliconware Precision Industries Co. Ltd. (NASDAQ:SPIL) announced that its consolidated sales revenues for the first quarter of 2015 were NT$ 20,805 million, which represented a 2.9% decline in revenues compared to the fourth quarter of 2014 and a 15.2% growth in revenues compared to the first quarter of 2014.

On last trading day Cempra, Inc. (NASDAQ:CEMP) moved down -0.47% to close at $33.76. Its volatility for the week is 6.91% while volatility for the month is 5.52%. CEMP’s EPS growth for past 5 years was -11.30%. Cempra, Inc. (NASDAQ:CEMP) monthly performance is -3.35%. Cempra, Inc. (NASDAQ:CEMP), announced that it will report first quarter 2015 financial results after the close of U.S. financial markets on April 30, 2015.